Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
358
-
Total 13F shares, excl. options
-
42.9M
-
Shares change
-
+807K
-
Total reported value, excl. options
-
$5.48B
-
Value change
-
+$109M
-
Put/Call ratio
-
0.79
-
Number of buys
-
158
-
Number of sells
-
-161
-
Price
-
$127.88
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q3 2018
408 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q3 2018.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 358 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 42.9M shares
of 44.8M outstanding shares and own 95.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.92M shares), Vanguard Group Inc (3.78M shares), FMR LLC (2.94M shares), AQR CAPITAL MANAGEMENT LLC (2.33M shares), STATE STREET CORP (2.07M shares), RENAISSANCE TECHNOLOGIES LLC (1.94M shares), Palo Alto Investors LP (1.63M shares), ACADIAN ASSET MANAGEMENT LLC (1.2M shares), GOLDMAN SACHS GROUP INC (1.12M shares), and DIMENSIONAL FUND ADVISORS LP (1.06M shares).
This table shows the top 358 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.